Molecular mechanism of Icariin on rat asthmatic model

Chinese Medical Journal

Volumn 124, Issue 18, 2011, Pages 2899-2906

  Xu, Chang Qing ^a   Le, Jing Jing ^a   Duan, Xiao Hong ^a   Du, Wei Jing ^a   Liu, Bao jun ^a   Wu, Jing feng ^a   Cao, Yu Xue ^a   Dong, Jing Cheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Icariin; Nuclear factor kappa B; P65; T bet GATA 3; Th1 th2

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; ICARIIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MESSENGER RNA; OVALBUMIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BLOOD VESSEL; BRONCHUS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSITIZATION; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ASTHMA; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; GATA3 TRANSCRIPTION FACTOR; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-4; LUNG; MALE; OVALBUMIN; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTOR RELA;

EID: 80053021015     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.18.019     Document Type: Article

References (31)

1. Park HJ, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol 2009; 9: 261-267.
2. Xates A, Callard R, Stark J. Combining cytokine signalling with T-bet and GATA-3 regulation in Th1 and Th2 differentiation: a model for cellular decision-making. J Theor Biol 2004; 231: 181-196.
3. Yu HR, Chang JC, Chen RF, Chuang H, Hong KC, Wang L, et al. Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression. J Leukoc Biol 2003; 74: 952-958.
4. Chakir H, Wang H, Lefebvre DE, Webb J, Scott FW. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods: 2003; 278: 157-169.
5. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology 2006; 45: 951-957.
6. Shao DZ, Lin M. Platonin inhibits LPS-induced NF-kappaB by preventing activation of Akt and IKKbeta in human PBMC. Inflamm Res 2008; 57: 601-606.
7. Andersen JN, Sathyanarayanan S, Di Bacco A, Chi A, Zhang T, Chen AH, et al. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Sci Transl Med 2010; 2: 43-55.
8. Park SY, Park GY, Ko WS, Kim Y. Dichroa febrifuga Lour. inhibits the production of IL-1beta and IL-6 through blocking NF-kappaB, MAPK and Akt activation in macrophages. J Ethnopharmacol 2009; 125: 246-251.
9. He W, Sun H, Yang B, Zhang D, Kabelitz D. Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung 1995; 45: 910-913.
10. Zhao F, Tang YZ, Liu ZQ. Protective effect of icariin on DNA against radical-induced oxidative damage. J Pharm Pharmacol 2007; 59: 1729-1732.
11. Vale-Pereira S, Todo-Bom A, Geraldes L, Schmidt-Weber C, Akdis CA, Mota-Pinto A. FoxP3, GATA-3 and T-bet expression in elderly asthma. Clin Exp Allergy 2011; 41: 490-496.
12. Neurath MF, Finotto S, Glimcher LH. Th1/Th2 lymphocyte polarization in asthma. Allergy Nat Med 2002; 8: 567-573.
13. Colavita AM, Reinach AJ, Peters SP. Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm. Clin Chest Med 2000; 21:263-277.
14. Nakanishi K. Pathological role of super Th1 cells in induction of atopic dermatitis and bronchial asthma. Arerugi 2008; 57: 989-994.
15. McGee HS, Agrawal DK. TH2 cells in the pathogenesis of airway remodeling: regulatory T cells a plausible panacea for asthma. Immunol Res 2006; 35: 219-232.
16. Nakamura Y, Hoshino M. TH2 cytokines and associated transcription factors as therapeutic targets in asthma. Curr Drug Targets Inflamm Allergy 2005; 4: 267-270.
17. Park HJ, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH, et al. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int Immunopharmacol 2009; 9: 261-267.
18. Fietta P, Delsante G. The effector T helper cell triade. Riv Biol 2009; 102: 61-74.
19. Wegmann M. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Rev Mol Diagn 2009; 9: 85-100.
20. Robinson DS, Lloyd CM. Asthma: T-bet a master controller? Curr Biol 2002 30; 12: R322-R324.
21. Wang SY, Yang M, Xu XP, Qiu GF, Ma J, Wang SJ, et al. Intranasal delivery of T-bet modulates the profile of helper T cell immune responses in experimental asthma. J Investig Allergol Clin Immunol 2008; 18: 357-365.
22. Raby BA, Hwang ES, Van Steen K, Tantisira K, Peng S, Litonjua A, et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med 2006; 173: 64-70.
23. Zhu J, Yamane H, Cote-Sierra J, Guo L, Paul WE. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006; 16: 3-10.
24. Barnes PJ. Role of GATA-3 in allergic diseases. Curr Mol Med 2008; 8: 330-334.
25. Sel S, Wegmann M, Dicke T, Sel S, Henke W, Yildirim AO, et al. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. J Allergy Clin Immunol 2008; 121: 910-916.
26. Erpenbeck VJ, Hohlfeld JM, Discher M, Krentel H, Hagenberg A, Braun A, et al. Increased messenger RNA expression of c-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. Chest 2003; 123(3 Suppl): s370-s371.
27. Wu JF, Dong JC, Xu CQ. Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo. Chin J Integ Tradit Western Med (Chin) 2009; 29: 330-334.
28. Charokopos N, Apostolopoulos N, Kalapodi M, Leotsinidis M, Karamanos N, Mouzaki A. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappa B. Curr Med Chem 2009; 6: 867-883.
29. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M, Johnston SL. Targeting the NF-kappa B pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 2009; 121: 1-13.
30. Bamborough P, Callahan JF, Christopher JA, Kerns JK, Liddle J, Miller DD, et al. Progress towards the development of anti-inflammatory inhibitors of IKKbeta. Curr Top Med Chem 2009; 9: 623-639.
31. Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX, et al. Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol 2010; 642: 146-153.